PH-triggered echogenicity and contents release from liposomes

Molecular Pharmaceutics

Volumn 11, Issue 11, 2014, Pages 4059-4068

  Nahire, Rahul ^a   Hossain, Rayat ^a   Patel, Rupa ^a   Paul, Shirshendu ^c   Meghnani, Varsha ^a   Ambre, Avinash H ^b   Gange, Kara N ^a   Katti, Kalpana S ^b   Leclerc, Estelle ^a   Srivastava, D K ^a   Sarkar, Kausik ^c,d   Mallik, Sanku ^a  

^a NORTH DAKOTA STATE UNIVERSITY   (United States)

^b North Dakota State University   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

^d The George Washington University   (United States)

Author keywords

Drug delivery; Echogenic liposomes; Pancreatic cancer; pH sensitive liposomes; Ultrasound

Indexed keywords

DOXORUBICIN; FOLATE RECEPTOR; LIPOSOME; ANTINEOPLASTIC AGENT; FOLATE RECEPTOR 1; MACROGOL DERIVATIVE; NANOPARTICLE;

ACIDITY; ARTICLE; ATOMIC FORCE MICROSCOPY; CARCINOMA CELL; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; DRUG FORMULATION; DRUG RELEASE; ECHOGRAPHY; ENCAPSULATION; GAS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; LYSOSOME; PANCREAS CARCINOMA; PH; PRIORITY JOURNAL; ULTRASOUND; ANALOGS AND DERIVATIVES; CARCINOMA, PANCREATIC DUCTAL; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR CELL CULTURE;

ANTINEOPLASTIC AGENTS; CARCINOMA, PANCREATIC DUCTAL; CELL MOVEMENT; CELL PROLIFERATION; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FOLATE RECEPTOR 1; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PANCREATIC NEOPLASMS; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED; ULTRASONICS;

EID: 84965184778     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500186a     Document Type: Article

References (58)

1. Kaye, S. B.; Richardson, V. J. Potential of liposomes as drugcarriers in cancer chemotherapy: a review. Cancer Chemother. Pharmacol. 1979, 3 (2), 81-5
2. Yang, F.; Jin, C.; Jiang, Y.; Li, J.; Di, Y.; Ni, Q.; Fu, D. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treat. Rev. 2011, 37 (8), 633-42
3. Yu, X.; Zhang, Y.; Chen, C.; Yao, Q.; Li, M. Targeted drug delivery in pancreatic cancer. Biochim. Biophys. Acta 2010, 1805 (1), 97-104
4. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discovery 2005, 4 (2), 145-60
5. Andresen, T. L.; Thompson, D. H.; Kaasgaard, T. Enzymetriggered nanomedicine: drug release strategies in cancer therapy. Mol. Membr. Biol. 2010, 27 (7), 353-63
6. Elegbede, A. I.; Banerjee, J.; Hanson, A. J.; Tobwala, S.; Ganguli, B.; Wang, R.; Lu, X.; Srivastava, D. K.; Mallik, S. Mechanistic studies of the triggered release of liposomal contents by matrix metalloproteinase-9. J. Am. Chem. Soc. 2008, 130 (32), 10633-42
7. Sarkar, N. R.; Rosendahl, T.; Krueger, A. B.; Banerjee, A. L.; Benton, K.; Mallik, S.; Srivastava, D. K. "Uncorking" of liposomes by matrix metalloproteinase-9. Chem. Commun. (Cambridge, U.K.) 2005, 8, 999-1001
8. Kulkarni, P. S.; Haldar, M. K.; Nahire, R. R.; Katti, P.; Ambre, A. H.; Muhonen, W. W.; Shabb, J. B.; Padi, S. K.; Singh, R. K.; Borowicz, P. P.; Shrivastava, D. K.; Katti, K. S.; Reindl, K.; Guo, B.; Mallik, S. MMP-9 Responsive PEG Cleavable Nanovesicles for Efficient Delivery of Chemotherapeutics to Pancreatic Cancer. Mol. Pharmaceutics 2014, 11 (7), 2390-9
9. Felber, A. E.; Dufresne, M. H.; Leroux, J. C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv. Drug Delivery Rev. 2012, 64 (11), 979-92
10. Leite, E. A.; Souza, C. M.; Carvalho-Junior, A. D.; Coelho, L. G.; Lana, A. M.; Cassali, G. D.; Oliveira, M. C. Encapsulation of cisplatin in long-circulating and pH-sensitive liposomes improves its antitumor effect and reduces acute toxicity. Int. J. Nanomed. 2012, 7, 5259-69
11. Kim, H. K.; Van den Bossche, J.; Hyun, S. H.; Thompson, D. H. Acid-triggered release via dePEGylation of fusogenic liposomes mediated by heterobifunctional phenyl-substituted vinyl ethers with tunable pH-sensitivity. Bioconjugate Chem. 2012, 23 (10), 2071-7
12. Yao, L.; Daniels, J.; Wijesinghe, D.; Andreev, O. A.; Reshetnyak, Y. K. pHLIP(R)-mediated delivery of PEGylated liposomes to cancer cells. J. Controlled Release 2013, 167 (3), 228-37
13. Wehunt, M. P.; Winschel, C. A.; Khan, A. K.; Guo, T. L.; Abdrakhmanova, G. R.; Sidorov, V. Controlled drug-release system based on pH-sensitive chloride-triggerable liposomes. J. Liposome Res. 2013, 23 (1), 37-46
14. Unnikrishnan, S.; Klibanov, A. L. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application. Am. J. Roentgenol. 2012, 199 (2), 292-9
15. Jing, Y.; Zhu, Y.; Yang, X.; Shen, J.; Li, C. Ultrasound-triggered smart drug release from multifunctional core-shell capsules one-step fabricated by coaxial electrospray method. Langmuir 2011, 27 (3), 1175-80
16. Wu, D.; Wan, M. A novel fluoride anion modified gelatin nanogel system for ultrasound-triggered drug release. J. Pharm. Pharm. Sci. 2008, 11 (4), 32-45
17. Huang, S. L.; MacDonald, R. C. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim. Biophys. Acta 2004, 1665 (1-2), 134-41
18. De Geest, B. G.; Skirtach, A. G.; Mamedov, A. A.; Antipov, A. A.; Kotov, N. A.; De Smedt, S. C.; Sukhorukov, G. B. Ultrasoundtriggered release from multilayered capsules. Small 2007, 3 (5), 804-8
19. Figueiredo, M.; Esenaliev, R. PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors. J. Drug Delivery 2012, 2012, 767839
20. Zhang, H.; Jiang, H.; Wang, H.; Zhao, J.; Chen, B.; Wang, X. Ultrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistance. J. Nanosci. Nanotechnol. 2011, 11 (3), 1834-40
21. Nahire, R.; Haldar, M. K.; Paul, S.; Ambre, A. H.; Meghnani, V.; Layek, B.; Katti, K. S.; Gange, K. N.; Singh, J.; Sarkar, K.; Mallik, S. Multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells. Biomaterials 2014, 35 (24), 6482-97
22. Barati, A. H.; Mokhtari-Dizaji, M.; Mozdarani, H.; Bathaie, S. Z.; Hassan, Z. M. Treatment of murine tumors using dual-frequency ultrasound in an experimental in vivo model. Ultrasound Med. Biol. 2009, 35 (5), 756-63
23. Shaw, G. J.; Meunier, J. M.; Huang, S. L.; Lindsell, C. J.; McPherson, D. D.; Holland, C. K. Ultrasound-enhanced thrombolysis with tPA-loaded echogenic liposomes. Thromb. Res. 2009, 124 (3), 306-10
24. Schroeder, A.; Honen, R.; Turjeman, K.; Gabizon, A.; Kost, J.; Barenholz, Y. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J. Controlled Release 2009, 137 (1), 63-8
25. Ahmadi, F.; McLoughlin, I. V.; Chauhan, S.; ter-Haar, G. Bioeffects and safety of low-intensity, low-frequency ultrasonic exposure. Prog. Biophys. Mol. Biol. 2012, 108 (3), 119-38
26. Alkan-Onyuksel, H.; Demos, S. M.; Lanza, G. M.; Vonesh, M. J.; Klegerman, M. E.; Kane, B. J.; Kuszak, J.; McPherson, D. D. Development of inherently echogenic liposomes as an ultrasonic contrast agent. J. Pharm. Pharm. Sci. 1996, 85 (5), 486-90
27. Paul, S.; Nahire, R.; Mallik, S.; Sarkar, K. Encapsulated microbubbles and echogenic liposomes for contrast ultrasound imaging and targeted drug delivery. Comput. Mech. 2014, 53 (3), 413-35
28. Nahire, R.; Haldar, M. K.; Paul, S.; Mergoum, A.; Ambre, A. H.; Katti, K. S.; Gange, K. N.; Srivastava, D. K.; Sarkar, K.; Mallik, S. Polymer-coated echogenic lipid nanoparticles with dual release triggers. Biomacromolecules 2013, 14 (3), 841-53
29. Radhakrishnan, K.; Haworth, K. J.; Huang, S. L.; Klegerman, M. E.; McPherson, D. D.; Holland, C. K. Stability of echogenic liposomes as a blood pool ultrasound contrast agent in a physiologic flow phantom. Ultrasound Med. Biol. 2012, 38 (11), 1970-81
30. Kopechek, J. A.; Haworth, K. J.; Raymond, J. L.; Douglas Mast, T.; Perrin, S. R.; Klegerman, M. E.; Huang, S.; Porter, T. M.; McPherson, D. D.; Holland, C. K. Acoustic characterization of echogenic liposomes: frequency-dependent attenuation and backscatter. J. Acoust. Soc. Am. 2011, 130 (5), 3472-81
31. Paul, S.; Russakow, D.; Nahire, R.; Nandy, T.; Ambre, A. H.; Katti, K.; Mallik, S.; Sarkar, K. In vitro measurement of attenuation and nonlinear scattering from echogenic liposomes. Ultrasonics 2012, 52 (7), 962-969
32. Smith, D. A.; Porter, T. M.; Martinez, J.; Huang, S.; MacDonald, R. C.; McPherson, D. D.; Holland, C. K. Destruction thresholds of echogenic liposomes with clinical diagnostic ultrasound. Ultrasound Med. Biol. 2007, 33 (5), 797-809
33. Nahire, R.; Paul, S.; Scott, M. D.; Singh, R. K.; Muhonen, W. W.; Shabb, J.; Gange, K. N.; Srivastava, D. K.; Sarkar, K.; Mallik, S. Ultrasound enhanced matrix metalloproteinase-9 triggered release of contents from echogenic liposomes. Mol. Pharmaceutics 2012, 9 (9), 2554-64
34. Chen, K. J.; Liang, H. F.; Chen, H. L.; Wang, Y.; Cheng, P. Y.; Liu, H. L.; Xia, Y.; Sung, H. W. A thermoresponsive bubble-generating liposomal system for triggering localized extracellular drug delivery. ACS Nano 2013, 7 (1), 438-46
35. Stathis, A.; Moore, M. J. Advanced pancreatic carcinoma: current treatment and future challenges. Nat. Rev. Clin. Oncol. 2010, 7 (3), 163-172
36. Klein, A. P. Identifying people at a high risk of developing pancreatic cancer. Nat. Rev. Cancer 2013, 13 (1), 66-74
37. Kremkau, F. W. Diagnostic Ultrasound; Principles and Instrumentations; Saunders: Philadephia, 2002
38. Kopechek, J. A.; Haworth, K. J.; Radhakrishnan, K.; Huang, S. L.; Klegerman, M. E.; McPherson, D. D.; Holland, C. K. The impact of bubbles on measurement of drug release from echogenic liposomes. Ultrasonics So ochem. 2013, 20 (4), 1121-30
39. Davis, P. J.; Fleming, B. D.; Coolbear, K. P.; Keough, K. M. Gel to liquid-crystalline transition temperatures of water dispersions of two pairs of positional isomers of unsaturated mixed-acid phosphatidylcholines. Biochemistry 1981, 20 (12), 3633-6
40. Chen, R. F.; Knutson, J. R. Mechanism of fluorescence concentration quenching of carboxyfluorescein in liposomes: energy transfer to nonfluorescent dimers. Anal. Biochem. 1988, 172 (1), 61-77
41. Shimshick, E. J.; McConnell, H. M. Lateral phase separation in phospholipid membranes. Biochemistry 1973, 12 (12), 2351-60
42. Chung, M. F.; Chen, K. J.; Liang, H. F.; Liao, Z. X.; Chia, W. T.; Xia, Y.; Sung, H. W. A liposomal system capable of generating CO2 bubbles to induce transient cavitation, lysosomal rupturing, and cell necrosis. Angew. Chem., Int. Ed. 2012, 51 (40), 10089-93
43. Leighton, T. G. The acoustic bubble, first printing pbk. ed.; Academic Press: San Diego, London, 1997; p xxvi, 613 pp
44. Liong, M.; Lu, J.; Kovochich, M.; Xia, T.; Ruehm, S. G.; Nel, A. E.; Tamanoi, F.; Zink, J. I. Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery. ACS Nano 2008, 2 (5), 889-96
45. Kratz, F.; Azab, S.; Zeisig, R.; Fichtner, I.; Warnecke, A. Evaluation of combination therapy schedules of doxorubicin and an acid-sensitive albumin-binding prodrug of doxorubicin in the MIA PaCa-2 pancreatic xenograft model. Int. J. Pharm. 2013, 441 (1-2), 499-506
46. Syrigos, K. N.; Michalaki, B.; Alevyzaki, F.; Machairas, A.; Mandrekas, D.; Kindilidis, K.; Karatzas, G. A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer. Anticancer Res. 2002, 22 (6B), 3583-8
47. Halford, S.; Yip, D.; Karapetis, C. S.; Strickland, A. H.; Steger, A.; Khawaja, H. T.; Harper, P. G. A phase II study evaluating the tolerability and efficacy of CAELYX (liposomal doxorubicin, Doxil) in the treatment of unresectable pancreatic carcinoma. Ann. Oncol. 2001, 12 (10), 1399-402
48. Mitragotri, S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat. Rev. Drug Discovery 2005, 4 (3), 255-60
49. Cochran, M. C.; Eisenbrey, J.; Ouma, R. O.; Soulen, M.; Wheatley, M. A. Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int. J. Pharm. 2011, 414 (1-2), 161-70
50. Huang, S. L.; McPherson, D. D.; Macdonald, R. C. A method to co-encapsulate gas and drugs in lip osomes for ultrasound-controlled drug delivery. Ultrasound Med. Biol. 2008, 34 (8), 1272-80
51. Lentacker, I.; Geers, B.; Demeester, J.; De Smedt, S. C.; Sanders, N. N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol. Ther. 2010, 18 (1), 101-8
52. Mehier-Humbert, S.; Bettinger, T.; Yan, F.; Guy, R. H. Plasma membrane poration induced by ultrasound exposure: implication for drug delivery. J. Controlled Release 2005, 104 (1), 213-22
53. Zirvi, K. A.; Hill, G. J. Comparison of growth and drug response of human tumor cells in serum-free and serum-supplemented media in human tumor-clonogenic assay. J. Surg. Oncol. 1988, 38 (2), 88-93
54. Wilkoff, L. J.; Dulmadge, E. A. Sensitivity of proliferating cultured murine pancreatic tumor cells to selected antitumor agents. J. Natl. Cancer Inst. 1986, 77 (5), 1163-9
55. Chang, B. K. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines. Cancer Res. 1983, 43 (7), 3147-9
56. Takada, M.; Hirata, K.; Ajiki, T.; Suzuki, Y.; Kuroda, Y. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells. Hepato-Gastroenterology 2004, 51 (58), 928-30
57. Ellenrieder, V.; Alber, B.; Lacher, U.; Hendler, S. F.; Menke, A.; Boeck, W.; Wagner, M.; Wilda, M.; Friess, H.; Buchler, M.; Adler, G.; Gress, T. M. Role of MT-MMPs and MMP-2 in pancreatic cancer progression. Int. J. Cancer 2000, 85 (1), 14-20
58. Frenkel, V. Ultrasound media-ted delivery of drugs and genes to solid tumors. Adv. Drug Delivery Rev. 2008, 60 (10), 1193-208.